Shenzhen Hepalink Pharmaceutical Group (002399)

Shenzhen Hepalink Pharmaceutical Group (002399)

$ 10

Trading Risk Analysis

English Version

Date : 1 Jan 2021


Shenzhen Hepalink Pharmaceutical Group Co Ltd is a China-based pharmaceutical company. The Company operates four segments. The Pharmaceutical Preparation segment is engaged in the production and sales of anticoagulant and antithrombotic pharmaceutical preparations, including enoxaparin sodium injection and heparin sodium injection. The Active Pharmaceutical Ingredient (API) segment operates the production and sales of API products, including enoxaparin sodium API and heparin sodium API. The contract development manufacturing organization (CDMO) segment provides full-cycle services for the process of developing drugs, including research and development, production, quality management, project management and commercialization. The Company also operates Other segment.


There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.

You may also like…

Close Bitnami banner